PHARMACOKINETICS AND BIOAVAILABILITY OF TRANEXAMIC ACIDPILBRANT A; SCHANNONG M; VESSMAN J et al.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 20; NO 1; PP. 65-72; BIBL. 14 REF.Article

DETERMINATION OF TRANEXAMIC ACID (AMCA) AND FIBRIN-FIBRINOGEN DEGRADATION PRODUCTS IN CEREBROSPINAL FLUID AFTER ANEURYSMAL SUBARACHNOID HAEMORRHAGEFODSTAD H; PILBRANT A; SCHANNONG M et al.1981; ACTA NEUROCHIR.; ISSN 0001-6268; AUT; DA. 1981; VOL. 58; NO 1-2; PP. 1-13; BIBL. 39 REF.Article

PHARMACOKINETICS OF TRANEXAMIC ACID AFTER INTRAVENOUS ADMINISTRATION TO NORMAL VOLUNTEERS = PHARMACOCINETIQUE DE L'ACIDE TRANEXAMIQUE APRES SON ADMINISTRATION INTRAVEINEUSE A DES VOLONTAIRES NORMAUXERIKSSON O; KJELLMAN H; PILBRANT A et al.1974; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1974; VOL. 7; NO 5; PP. 375-380; BIBL. 6REF.Article

Pharmacokinetics and pharmacodynamics of emepronium bromide (Cetiprin^®) after intravenous administration in manPILBRANT, Å; NORLEN, L. J.Acta pharmacologica et toxicologica. 1985, Vol 56, Num 4, pp 289-297, issn 0001-6683Article

VITAMIN B₁₂ BODY STORES DURING ORAL AND PARENTERAL TREATMENT OF PERNICIOUS ANAEMIABERLIN R; BERLIN H; BRANTE G et al.1978; ACTA MED. SCAND.; SWE; DA. 1978; VOL. 204; NO 1-2; PP. 81-84; BIBL. 5 REF.Article